GEHC
GE HealthCare Technologies Inc.
Medical - Healthcare Information Services
Market Cap$27.90B
5Y Perf.+5.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
GEHC vs PHG
Revenue, margins, valuation, and 5-year total return — side by side.
PHG
Koninklijke Philips N.V.
Medical - Devices
Market Cap$25.84B
5Y Perf.+81.2%
GEHC vs PHG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | GEHC | PHG |
|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Devices |
| Market Cap | $27.90B | $25.84B |
| Revenue (TTM) | $19.95B | $17.83B |
| Net Income (TTM) | $1.50B | $895M |
| Gross Margin | 42.5% | 45.2% |
| Operating Margin | 12.5% | 8.0% |
| Forward P/E | 12.4x | 17.5x |
| Total Debt | $10.00B | $8.09B |
| Cash & Equiv. | $4.51B | $2.79B |
GEHC vs PHG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
GEHC
PHG
| Stock | Dec 22 | May 26 | Return |
|---|---|---|---|
| GE HealthCare Techn… (GEHC) | 100 | 105.1 | +5.1% |
| Koninklijke Philips… (PHG) | 100 | 181.2 | +81.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEHC vs PHG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: GEHC leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Koninklijke Philips N.V. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
GEHC
GE HealthCare Technologies Inc.
The Growth Play
GEHC carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 4.8%, EPS growth 4.8%, 3Y rev CAGR 4.0%
- 4.8% revenue growth vs PHG's -1.0%
- Lower P/E (12.4x vs 17.5x)
Best for: growth exposure
PHG
Koninklijke Philips N.V.
The Income Pick
PHG is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.12, yield 1.5%
- 48.3% 10Y total return vs GEHC's 2.9%
- Lower volatility, beta 1.12, Low D/E 73.6%, current ratio 1.32x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | GEHC | 4.8% revenue growth vs PHG's -1.0% |
| Value | GEHC | Lower P/E (12.4x vs 17.5x) |
| Quality / Margins | GEHC | 7.5% margin vs PHG's 5.0% |
| Stability / Safety | PHG | Beta 1.12 vs GEHC's 1.37, lower leverage |
| Dividends | PHG | 1.5% yield, 1-year raise streak, vs GEHC's 0.2% |
| Momentum (1Y) | PHG | +17.7% vs GEHC's -10.7% |
| Efficiency (ROA) | GEHC | 4.1% ROA vs PHG's 3.4%, ROIC 13.3% vs 6.4% |
GEHC vs PHG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
GEHC vs PHG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLGEHCLAGGINGPHG
PHGKoninklijke Philips N…
2leads
GEHCGE HealthCare Technol…
3leads
6 Total Categories
CATEGORYLEADERvs PHGMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
GEHC4/6
Valuation MetricsMultiples, price ratios, and targets
GEHC4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
GEHC5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
PHG5/6
Risk & VolatilityBeta, volatility, and downside exposure
PHG2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
GEHC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC and PHG operate at a comparable scale, with $20.0B and $17.8B in trailing revenue. Profitability is closely matched — net margins range from 7.5% (GEHC) to 5.0% (PHG). On growth, GEHC holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | GEHCGE HealthCare Tec… | PHGKoninklijke Phili… |
|---|---|---|
| RevenueTrailing 12 months | $20.0B | $17.8B |
| EBITDAEarnings before interest/tax | $3.3B | $2.5B |
| Net IncomeAfter-tax profit | $1.5B | $895M |
| Free Cash FlowCash after capex | $1.5B | $755M |
| Gross MarginGross profit ÷ Revenue | +42.5% | +45.2% |
| Operating MarginEBIT ÷ Revenue | +12.5% | +8.0% |
| Net MarginNet income ÷ Revenue | +7.5% | +5.0% |
| FCF MarginFCF ÷ Revenue | +7.6% | +4.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.4% | +1.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -30.9% | +2.1% |
GEHC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
GEHC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, GEHC trades at a 46% valuation discount to PHG's 24.9x P/E. On an enterprise value basis, GEHC's 10.0x EV/EBITDA is more attractive than PHG's 10.7x.
| Metric | GEHCGE HealthCare Tec… | PHGKoninklijke Phili… |
|---|---|---|
| Market CapShares × price | $27.9B | $25.8B |
| Enterprise ValueMkt cap + debt − cash | $33.4B | $32.1B |
| Trailing P/EPrice ÷ TTM EPS | 13.48x | 24.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.40x | 17.55x |
| PEG RatioP/E ÷ EPS growth rate | 19.78x | — |
| EV / EBITDAEnterprise value multiple | 10.00x | 10.70x |
| Price / SalesMarket cap ÷ Revenue | 1.35x | 1.23x |
| Price / BookPrice ÷ Book value/share | 2.66x | 2.02x |
| Price / FCFMarket cap ÷ FCF | 18.53x | 24.62x |
GEHC leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
GEHC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $8 for PHG. PHG carries lower financial leverage with a 0.74x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEHC's 0.94x. On the Piotroski fundamental quality scale (0–9), PHG scores 7/9 vs GEHC's 4/9, reflecting strong financial health.
| Metric | GEHCGE HealthCare Tec… | PHGKoninklijke Phili… |
|---|---|---|
| ROE (TTM)Return on equity | +14.4% | +8.2% |
| ROA (TTM)Return on assets | +4.1% | +3.4% |
| ROICReturn on invested capital | +13.3% | +6.4% |
| ROCEReturn on capital employed | +10.8% | +7.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.94x | 0.74x |
| Net DebtTotal debt minus cash | $5.5B | $5.3B |
| Cash & Equiv.Liquid assets | $4.5B | $2.8B |
| Total DebtShort + long-term debt | $10.0B | $8.1B |
| Interest CoverageEBIT ÷ Interest expense | 5.35x | 4.34x |
GEHC leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
PHG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEHC five years ago would be worth $10,293 today (with dividends reinvested), compared to $5,734 for PHG. Over the past 12 months, PHG leads with a +17.7% total return vs GEHC's -10.7%. The 3-year compound annual growth rate (CAGR) favors PHG at 11.6% vs GEHC's -8.0% — a key indicator of consistent wealth creation.
| Metric | GEHCGE HealthCare Tec… | PHGKoninklijke Phili… |
|---|---|---|
| YTD ReturnYear-to-date | -25.9% | +0.3% |
| 1-Year ReturnPast 12 months | -10.7% | +17.7% |
| 3-Year ReturnCumulative with dividends | -22.2% | +38.8% |
| 5-Year ReturnCumulative with dividends | +2.9% | -42.7% |
| 10-Year ReturnCumulative with dividends | +2.9% | +48.3% |
| CAGR (3Y)Annualised 3-year return | -8.0% | +11.6% |
PHG leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
PHG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PHG is the less volatile stock with a 1.12 beta — it tends to amplify market swings less than GEHC's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PHG currently trades 81.2% from its 52-week high vs GEHC's 68.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | GEHCGE HealthCare Tec… | PHGKoninklijke Phili… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.37x | 1.12x |
| 52-Week HighHighest price in past year | $89.77 | $33.44 |
| 52-Week LowLowest price in past year | $58.75 | $21.95 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +81.2% |
| RSI (14)Momentum oscillator 0–100 | 32.1 | 47.7 |
| Avg Volume (50D)Average daily shares traded | 4.3M | 1.0M |
PHG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — GEHC and PHG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates GEHC as "Buy" and PHG as "Hold". For income investors, PHG offers the higher dividend yield at 1.47% vs GEHC's 0.23%.
| Metric | GEHCGE HealthCare Tec… | PHGKoninklijke Phili… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $84.00 | — |
| # AnalystsCovering analysts | 18 | 22 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +1.5% |
| Dividend StreakConsecutive years of raises | 3 | 1 |
| Dividend / ShareAnnual DPS | $0.14 | $0.34 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | 0.0% |
Evenly matched — GEHC and PHG each lead in 1 of 2 comparable metrics.
Key Takeaway
GEHC leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). PHG leads in 2 (Total Returns, Risk & Volatility). 1 tied.
Best OverallGE HealthCare Technologies … (GEHC)Leads 3 of 6 categories
Loading custom metrics...
GEHC vs PHG: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is GEHC or PHG a better buy right now?
For growth investors, GE HealthCare Technologies Inc.
(GEHC) is the stronger pick with 4. 8% revenue growth year-over-year, versus -1. 0% for Koninklijke Philips N. V. (PHG). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate GE HealthCare Technologies Inc. (GEHC) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GEHC or PHG?
On trailing P/E, GE HealthCare Technologies Inc.
(GEHC) is the cheapest at 13. 5x versus Koninklijke Philips N. V. at 24. 9x. On forward P/E, GE HealthCare Technologies Inc. is actually cheaper at 12. 4x.
03Which is the better long-term investment — GEHC or PHG?
Over the past 5 years, GE HealthCare Technologies Inc.
(GEHC) delivered a total return of +2. 9%, compared to -42. 7% for Koninklijke Philips N. V. (PHG). Over 10 years, the gap is even starker: PHG returned +48. 3% versus GEHC's +2. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GEHC or PHG?
By beta (market sensitivity over 5 years), Koninklijke Philips N.
V. (PHG) is the lower-risk stock at 1. 12β versus GE HealthCare Technologies Inc. 's 1. 37β — meaning GEHC is approximately 22% more volatile than PHG relative to the S&P 500. On balance sheet safety, Koninklijke Philips N. V. (PHG) carries a lower debt/equity ratio of 74% versus 94% for GE HealthCare Technologies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GEHC or PHG?
By revenue growth (latest reported year), GE HealthCare Technologies Inc.
(GEHC) is pulling ahead at 4. 8% versus -1. 0% for Koninklijke Philips N. V. (PHG). On earnings-per-share growth, the picture is similar: Koninklijke Philips N. V. grew EPS 224. 0% year-over-year, compared to 4. 8% for GE HealthCare Technologies Inc.. Over a 3-year CAGR, GEHC leads at 4. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GEHC or PHG?
GE HealthCare Technologies Inc.
(GEHC) is the more profitable company, earning 10. 1% net margin versus 5. 0% for Koninklijke Philips N. V. — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEHC leads at 13. 4% versus 8. 0% for PHG. At the gross margin level — before operating expenses — PHG leads at 45. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GEHC or PHG more undervalued right now?
On forward earnings alone, GE HealthCare Technologies Inc.
(GEHC) trades at 12. 4x forward P/E versus 17. 5x for Koninklijke Philips N. V. — 5. 1x cheaper on a one-year earnings basis.
08Which pays a better dividend — GEHC or PHG?
All stocks in this comparison pay dividends.
Koninklijke Philips N. V. (PHG) offers the highest yield at 1. 5%, versus 0. 2% for GE HealthCare Technologies Inc. (GEHC).
09Is GEHC or PHG better for a retirement portfolio?
For long-horizon retirement investors, Koninklijke Philips N.
V. (PHG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 12), 1. 5% yield). Both have compounded well over 10 years (PHG: +48. 3%, GEHC: +2. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GEHC and PHG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GEHC is a mid-cap deep-value stock; PHG is a mid-cap quality compounder stock. PHG pays a dividend while GEHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(GEHC: 7.4% · PHG: 1.1%)Net Margin>
%
(GEHC: 7.5% · PHG: 5.0%)P/E Ratio<
x
(GEHC: 13.5x · PHG: 24.9x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.